Jose Manuel Arencibia Jimenez

Title: Innovations of Jose Manuel Arencibia Jimenez

Introduction

Jose Manuel Arencibia Jimenez is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target cancer treatment. With a total of 2 patents, his work focuses on innovative solutions for inhibiting cancer cell proliferation.

Latest Patents

One of his latest patents is for 5-carboxamide-2-thiobarbituric acids and their use as medicaments. This invention relates to a class of derivatives that inhibit the human type II topoisomerase (topoII) enzyme, which is crucial in cancer cell proliferation. The patent also outlines a method for manufacturing these derivatives. Another significant patent involves 4-amino-2-pyrido-bicyclic pyrimidines, which serve as type II topoisomerase inhibitors. This invention also provides a method for their manufacture and emphasizes their potential in cancer treatment.

Career Highlights

Throughout his career, Jose Manuel Arencibia Jimenez has worked with esteemed institutions such as Università Degli Studi Di Padova and Fondazione Istituto Italiano Di Tecnologia. His research has been pivotal in advancing the understanding of topoisomerase inhibitors and their applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Marco De Vivo and Claudia Sissi. These partnerships have contributed to the successful development of his innovative patents.

Conclusion

Jose Manuel Arencibia Jimenez is a prominent figure in the field of medicinal chemistry, with a focus on cancer treatment innovations. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.